Skip to main content
. Author manuscript; available in PMC: 2019 Dec 1.
Published in final edited form as: J Surg Res. 2018 Jul 14;232:283–292. doi: 10.1016/j.jss.2018.06.040

Figure 2:

Figure 2:

CYD0618 decreases HSC viability (A) LX-2 and (B) HSC-T6 cell viability after treatment with a series of concentrations of CYD0618 for 48 hours. Western blots for LX-2 whole cell lysate after incubation with CYD0618 for cell growth arrest markers (C) p21 and (D) p27. P-values shown compared to vehicle. Densitometric analyses of bands were quantified and data expressed as fold of control normalized to GAPDH. All P-values shown compared to vehicle.